Exact Sciences Corp
—- Market cap
- —
- Debt
- +$2.85B
- Cash
- −$964.71M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: EXAS stock price vs EPRT Holdings, LLC: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at EPRT Holdings, LLC's multiple
Needs EPRT Holdings, LLC P/S.
Implied fair value · at EXAS's multiple
Needs Revenue / share, EXAS P/S.
Engine logicEXASvalued onEPRT Holdings, LLC’smultiple
Metric by metric
Where each company leads, and how wide the gap is.
Price unavailable
Higher is better
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: EXAS FY 2025 (ended Dec 31, 2025) · EPRT Holdings, LLC Latest annual filing. Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
EXACT SCIENCES CORP · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
EPRT Holdings, LLC · implied price per share
Reporting currency could not be verified.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
EPRT Holdings, LLC · not enough data.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
1.19x
—
Net debt / EBITDA
Leverage against operating earnings
35.68x
—
Cash and equivalents
Liquid reserves on the balance sheet
$964.71M
—
Total debt
Interest-bearing obligations outstanding
$2.85B
—
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.